Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis.
Boguniewicz
M
M
Sampson
H
H
Leung
S B
SB
Harbeck
R
R
Leung
D Y
DY
D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D000942:Antigens, Bacterial; D002444:Cefuroxime / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D003876:Dermatitis, Atopic / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011355:Prodrugs / Q000627:therapeutic use; D013207:Staphylococcal Skin Infections / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects*; D018089:Superantigens
D000305:Adrenal Cortex Hormones; D000942:Antigens, Bacterial; D002511:Cephalosporins; D011355:Prodrugs; D018089:Superantigens; D002444:Cefuroxime; C040738:cefuroxime axetil